Results 131 to 140 of about 9,268 (209)

Investigating the Sudan virus outbreak in Uganda through the deployment of a mobile laboratory. [PDF]

BMC Infect Dis
Pimundu G, Muyigi T, Nambozo EJ, Okiira C, Kanamwanji B, Nalwanga R, Sekate J, Mugabe R, Naiga J, Sewanyana I, Lutwama J, Balinandi S, Kaleebu P, Aceng JR, Atwiine D, Mwebesa H, Bosa HK, Kagirita A, Olaro C, Nsawotebba A, Achol E, Lagu H, Nzeyimana E, May J, Gehre F, Affara M, Nabadda S.   +26 more
europepmc   +1 more source

A tool of the trade for a newly identified filovirus: pseudovirus-based system for Dehong virus entry and neutralization. [PDF]

Microbiol Spectr
Biswas B.
europepmc   +1 more source

A diagnostic void in the Congo Basin: proposing a zoonotic orthopoxvirus as the cause of a hemorrhagic fever outbreak and a call for equitable health security. [PDF]

Infect Dis Poverty
Tshimbombu TN.
europepmc   +1 more source

Antiviral defense against filovirus infections: targets and evasion mechanisms. [PDF]

Future Microbiol
Bodmer BS, Wendt L, Dupré J, Groseth A, Hoenen T.   +4 more
europepmc   +1 more source

Identification of novel small chemical compounds that inhibit Ebola virus VP40-mediated virus-like particle production. [PDF]

Virus Res
Tsuruta T, Mizuta S, Izumisawa A, Yasuda J, Urata S.   +4 more
europepmc   +1 more source

Potential clinical treatment for Ebola pandemic [PDF]

, 2014
Jun Xu, MiaoMiao Sheng, TaiSheng Li, XueZhong Yu, Ying Zhong   +4 more
core   +1 more source

Nucleoprotein and glycoprotein based serological assays for detection of Marburg virus infections. [PDF]

EBioMedicine
Kagame J, Kainulainen MH, Kabalisa E, Brangel P, Uwimana JMV, Harmon JR, Mohamed NS, Benimana JL, Umwari A, Karaaslan E, Gasengayire A, Akimana J, Murenzi H, Kabageni C, Sealy T, Rwagitinywa B, Gashegu M, Ahmed A, Jain S, Albariño CG, Choi MJ, Schuh AJ, Firew T, Karekezi E, Mwesigwa RCN, Tuyishime A, Towner JS, Roels TH, Mukagatare I, Dowling WE, Montgomery JM, Muvunyi CM, Spiropoulou CF, Ngabonziza JCS, Bergeron É.   +34 more
europepmc   +1 more source

An intrinsically disordered peptide from Ebola virus VP35 controls viral RNA synthesis by modulating nucleoprotein-RNA interactions [PDF]

, 2015
Amarasinghe, Gaya K, Binning, Jennifer M, et al,, Harvey, Ian B, Leung, Daisy, Liu, Gai, Pan, Juanli   +6 more
core   +2 more sources

Risk group-4 virus emergent threats. [PDF]

Bioinformation
Shapshak P, Balaji S, Somboonewit C, T Sinnott J, Chiappelli F.   +4 more
europepmc   +1 more source

Safety, tolerability, immunogenicity, and plasmapheresis-based antibody collection in a phase 1b open label trial of two investigational monovalent chimpanzee adenoviral vectored filovirus vaccines, cAd3-Sudan and cAd3-Marburg, in healthy adults. [PDF]

EBioMedicine
Vert-Wong E, Stevenson ME, Rustomjee R, Finch CL, Jakubik J, King TH.   +5 more
europepmc   +1 more source